Foreigners gearing up for bigger bite of Korean pharmaceutical market

Published: 2007-01-10 07:00:00

Updated: 2007-01-10 07:00:00

Multinational drug makers are focusing on Korea's pharmaceutical market for osteoporosis, hepatitis B and diabetes, expecting its surging demand as the country ages. Competition is about to heat up in the domestic medicine market, as more and more new medicines are lining up side by side with dom...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK